Health Care Valuations Based on QALY Undercut the Fight Against Chronic Disease

09:01 EST 21 Nov 2019 | Businesswire
This article has expired, however you can still download the PDF.
Ethical questions loom over innovative efforts that can save lives The Partnership to Fight Chronic Disease (PFCD) has released the following statement regarding the National Council on Disability’s recent report, “Quality-Adjusted Life Years and the...

Other Sources for this Article

Jennifer Burke


More From BioPortfolio on "Health Care Valuations Based on QALY Undercut the Fight Against Chronic Disease"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...